ampicillin (9.4-71.1%), trimethoprim/sulfamethoxazole (11.1-67.5%) and streptomycin (21.9-69.3%), whereas none were resistant to imipenem or amikacin.
M a n u s c r i p t 
Introduction
The World Health Organization (WHO) has recently highlighted the major public health risks posed by resistance to critically important antimicrobials (CIAs) such as extended-spectrum cephalosporins (ESCs), fluoroquinolones (FQs) and carbapenems among Enterobacteriaceae [1] . Concerns are heightened when such resistance occurs in food-producing animals because of the potential risk of transmission to humans through the food chain and/or the environment [2, 3] .
Plasmid-mediated ESC resistance (mediated by bla CMY-2 ) was first detected in
Escherichia coli from US livestock in 1996 and in Salmonella Newport shortly thereafter in Canada [4, 5] . Similarly, in Asia and Europe, ESC resistance in E. coli isolated from livestock has been attributed to the emergence and spread of plasmidmediated bla CTX-M genes and bla CMY-2 [6] [7] [8] . In several countries in these regions, extensive use of FQs in some food-animal species has been linked to the emergence of FQ-resistant E. coli and Salmonella [9, 10] . More recently, carbapenemases (NDM-1, VIM, OXA-23) have been detected in Enterobacteriaceae isolated from livestock systems both in Asia and Europe [3] .
Recent studies have suggested that the ecology of antimicrobial resistance among Enterobacteriaceae isolated from food-producing animals in Australia is different to that in other parts of the world [11, 12] . Resistance to ESCs, FQs and carbapenems has yet to be reported among Enterobacteriaceae from Australian livestock [11, 12] .
This has been attributed to Australia's geographic isolation, restrictions placed on the importation of live animals and some foods, and strong regulation governing the use of CIAs [13, 14] . The latter includes bans on the use of FQs and carbapenems in any M a n u s c r i p t food-producing animal and of ceftiofur (an ESC) for mass medication [13] . In this study, we sought to define the frequency of resistance to these three critically important classes of antimicrobial among E. coli isolates causing clinical disease in Australian food-producing animals.
Materials and methods

Bacterial strains
A collection of 324 clinical E. coli isolates from Australian food-producing animals was compiled within the first national Australian veterinary antimicrobial resistance survey, which took place over 12 months (January 2013 to January 2014) with the co-operation of all veterinary diagnostic laboratories (n = 22) in all Australian states and territories. The study isolates were from bovine (n = 169), porcine (n = 114), poultry (n = 32) and ovine (n = 9) and were considered by the diagnostic microbiologist to be involved in the aetiology of the presenting disease. [15] . In addition, all ESC-and FQ-resistant isolates underwent ciprofloxacin and enrofloxacin MIC testing in the presence of the efflux pump inhibitor Phe-Arg-β-naphthylamide (PAβN) at 64 mg/L [17] . Isolates resistant to at least three antimicrobial classes were classed as multidrug-resistant (MDR).
Phenotypic detection of antimicrobial resistance
Molecular characterisation of Escherichia coli resistant to critically important antimicrobials
All ESC-and FQ-resistant isolates underwent PCR-based phylotyping [18] , identification of bla CTX-M and bla CMY-2 genes by PCR and amplicon sequencing [12] , plasmid replicon typing [19, 20] , screening for virulence genes typical of bovine and porcine enterotoxigenic E. coli (ETEC) (f4, f5, f6, f18, lt1, sta, stb and stx2e) [21] and multilocus sequence typing (MLST) (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli) as previously described. PCR and amplicon-sequencing of the quinolone resistancedetermining region (QRDR) for the gyrA, gyrB, parC and parE genes and plasmidmediated quinolone resistance (PMQR) genes qnrA, qnrB, qnrS, qepA, aac(6')-Ib and aac(6')-Ib-cr were performed as previously described [17, 22] .
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Plasmid characterisation
Plasmid characterisation was performed by S1 pulsed-field gel electrophoresis (PFGE) and in-gel hybridisation. Genomic DNA in agarose blocks was digested with the restriction enzyme S1 (Invitrogen, Abingdon, UK). DNA fragments were separated by PFGE. In-gel hybridisation was done with a bla CMY and bla CTX-M probe labelled with ³²P by random priming using 9-mer oligomers and a commercial kit (Stratagene, Amsterdam, The Netherlands).
Statistical analysis
The prevalence of resistance amongst the animal species groups was evaluated using Fisher's exact test.
Results
Phenotypic characterisation of antimicrobial resistance
The 324 E. coli isolates from food animal sources exhibited a high prevalence of resistance to tetracycline, ampicillin, SXT and streptomycin, whereas none were resistant to imipenem or amikacin (Table 1 ). Resistance to ESCs (ceftiofur and/or ceftazidime) was detected in five isolates (1.5%) [two bovine (1.2%) and three porcine (2.6%)] (Tables 1 and 2 ). These ESC-resistant phenotypes were confirmed by MIC testing to ESCs (ceftiofur, ceftriaxone, cefovecin and/or ceftazidime; Table   2 ). One of the porcine isolates (#03/13/4/59) was also resistant to ciprofloxacin. The FQ-resistant phenotype was confirmed by ciprofloxacin, enrofloxacin, moxifloxacin and pradofloxacin MIC testing (Table 2) .
Overall, in comparison with bovine, ovine and poultry isolates, porcine isolates demonstrated a higher resistance prevalence for most antimicrobial agents (Table   1 ). These differences between species were statistically significant (P < 0.05) for 13 of the 18 antimicrobials evaluated in this study. Porcine isolates demonstrated a remarkably high frequency of resistance to tetracycline, ampicillin, SXT, streptomycin, chloramphenicol, apramycin, florfenicol and gentamicin (Table 1) .
Among the isolates characterised in this study, 79% of porcine, 33% of poultry, 26%
of bovine and 22% of ovine isolates qualified as MDR.
Molecular characterisation of Escherichia coli resistant to critically important antimicrobials
Molecular characterisation of the ESC-resistant isolates revealed that bla CMY-2 , bla CTX-M-14 and bla CTX-M-9 were the genes that encoded ESC resistance among the E.
coli isolates in this study. Molecular characterisation also showed that only one isolate (ST100) was a classic porcine ETEC isolate based on the presence of ETEC virulence genes f4, f6, lt1 and stb ( Table 2 A c c e p t e d M a n u s c r i p t
Characterisation of plasmids from Escherichia coli resistant to critically important antimicrobials
Plasmid characterisation by S1 PFGE revealed a number of different plasmids among the ESC-resistant E. coli isolates. Each ESC-resistant E. coli strain contained one to five plasmids (Table 3 ). Probe hybridisation revealed that bla CMY-2 and bla CTX-M-14 were carried on plasmids, whilst bla CTX-M-9 was present on the chromosomal DNA. One of the strains (#03/13/4/91) also carried bla CMY-2 on the chromosomal DNA ( Table 3 ). The ESC-resistant plasmids were of different sizes, ranging from 75 kb to 250 kb ( Table 3) . One of the isolates (#02/13/1/13) appeared to have lost a number of plasmids, including the bla CMY-2 -bearing plasmid, following storage at -80 °C (Table 3) . However, this isolate still maintained one of the ESC resistance plasmids containing bla CTX-M-14 .
Discussion
Here we report the first detection of ESC-and FQ-resistant E. coli from Australian food-producing animals. The presence of bla CTXM-14 , bla CTX-M-9 and bla CMY-2 in E. coli from food-producing animals is of potential public health significance because of the risk of direct transfer of such strains to humans via the food chain or environment and/or through the mobilisation of plasmids that can potentially transfer the ESC resistance genes to other Gram-negative bacteria, including Salmonella spp. A c c e p t e d M a n u s c r i p t
and Europe, but also as a sporadic cause of human extraintestinal infections in Canada, Chile, France, Spain and Brazil [23, 24] (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). ST10 is an extremely diverse and broadhost-range lineage causing extraintestinal infections in hospitalised and communitydwelling humans in The Netherlands and Canada [24] [25] [26] , and is also detected in poultry, wild birds and pigs as well as retail chicken and pork meat [24] [25] [26] [27] . ST1 has also been reported to be both a pig and a human pathogen in Germany (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). Finally, the ESC-and FQ-resistant strain (ST744) has been identified previously as an extended-spectrum β-lactamase (ESBL)-producing lineage associated with wild birds in Bangladesh and with human extraintestinal infection in Laos [28] . This demonstrates that these ESC-resistant E.
coli strains are potentially strains that may move bidirectionally between humans and animals.
To our knowledge, these ESC-resistant E. coli strains belonging to the sequence types identified in this study have not been reported previously in Australia either from food-producing animals or as a cause of human infection. Their low frequency among clinical isolates from Australian animals suggests that they have potentially been introduced. This plausibly could occur via either human carriers or migratory wild birds due to Australian quarantine restrictions on the importation of livestock and regulation on the use of CIAs in livestock [13, 14, 25, 27, 28] . Australia has banned the importation of livestock since the 1970s [14] , and FQs cannot legally be administered to food-producing animals in this country [13] . Furthermore, ESC-resistant clones identified in this study have also been detected among humans and birds in other continents as previously described. Therefore, it is unlikely that strains such as M a n u s c r i p t ST744-A, which is resistant both to ESCs and FQs, evolved from an animalassociated susceptible progenitor strain under local FQ selection pressure.
The detection of a single ESC-resistant porcine ETEC (ST100-A) strain carrying bla CMY-2 is potentially significant for animal health. Our previous study on porcine ETEC identified ST100 as a prominent clonal lineage among Australian porcine ETEC isolates of serogroup O149, and the majority of these clones are resistant to a wider range of antimicrobials that are regularly used to treat post-weaning diarrhoea [12] . However, none of the O149/ST100 ETEC isolates in that study were ESCresistant [12] . This is the first time ESC resistance has been reported in Australian porcine ETEC. In Australia, ceftiofur (an ESC) is used as a last-line off-label antimicrobial for parenteral treatment of seriously ill pigs with MDR ETEC infection.
Therefore, detection of ESC-resistant porcine O149/ST100 ETEC has potential animal health implications in Australia owing to the limited therapeutic options.
Detection of ESC resistance in a single Australian porcine ETEC isolate indicates a need for both ongoing surveillance at the national level and closer scrutiny of the offlabel use of ESCs to avoid the spread of ESC-resistant ETEC in Australian pig herds.
Despite the detection of ESC-resistant E. coli clones from food-producing animals in
Australia, it is difficult to evaluate the public health impact of the detected ESCresistant E. coli clones. This is because there are limited data regarding the CTX-M and CMY types detected among human clinical E. coli isolates in Australia. The
Australian human Gram-negative surveillance reports the ESC-resistant isolates as CTX-M or CMY without identifying the specific types [29] . Therefore, it is difficult to M a n u s c r i p t research grants, contracts or honoraria from Crucell, ICET, Merck, Syntiron and
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